Fundraising Fox
🦊/Companies
Sign in

Vesalio

Founded 2017 · 65 employees on LinkedIn · 1 known investors

Find your way into Vesalio

Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.

Deep TechHealthtechMedical Devices

Founders & leadership

Vesalio was founded in 2017 by Arthur J. Ulm.

AJArthur J. Ulm
Arthur J. UlmCTO/Founder/Board Member

Investors · 1

Solas BioVenturesChattanooga

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Vesalio Raises Funding to Support Expansion of Vascular Occlusion Treatments to United States Market - Endovascular Todayevtoday.com · May 2022Vesalio announces oversubscribed Class A financing - Vesaliovesalio.com · May 2022Vesalio Secures Class A Funding - Vesaliovesalio.com · Jul 2021Vesalio™ Secures $5 Million Investment Capital Funding - Vesaliovesalio.com · Jul 2021Vesalio Leadership Team | Vesalio Executive Team - Vesaliovesalio.com · Jun 2021Vesalio Secures Funding to Support Its Neurovascular Product Portfolio - Endovascular Todayevtoday.com · Jun 2021

Frequently asked questions

What does Vesalio do?
Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.
Who founded Vesalio?
Vesalio was founded by Arthur J. Ulm in 2017.
Who are Vesalio's investors?
Vesalio's investors include Solas BioVentures.